DK0680765T3 - Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme - Google Patents

Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme

Info

Publication number
DK0680765T3
DK0680765T3 DK95302996T DK95302996T DK0680765T3 DK 0680765 T3 DK0680765 T3 DK 0680765T3 DK 95302996 T DK95302996 T DK 95302996T DK 95302996 T DK95302996 T DK 95302996T DK 0680765 T3 DK0680765 T3 DK 0680765T3
Authority
DK
Denmark
Prior art keywords
haemophilus influenzae
vaccine
influenzae strain
typeable haemophilus
protein
Prior art date
Application number
DK95302996T
Other languages
Danish (da)
English (en)
Inventor
Gary Warren Zlotnick
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0680765T3 publication Critical patent/DK0680765T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK95302996T 1994-05-05 1995-05-02 Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme DK0680765T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/210,394 US5770213A (en) 1994-05-05 1994-05-05 Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection

Publications (1)

Publication Number Publication Date
DK0680765T3 true DK0680765T3 (da) 2007-07-02

Family

ID=22782738

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95302996T DK0680765T3 (da) 1994-05-05 1995-05-02 Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme

Country Status (14)

Country Link
US (2) US5770213A (ja)
EP (1) EP0680765B1 (ja)
JP (2) JP4236215B2 (ja)
KR (1) KR100366482B1 (ja)
AT (1) ATE356633T1 (ja)
AU (1) AU704882B2 (ja)
CA (1) CA2148563C (ja)
DE (1) DE69535422T2 (ja)
DK (1) DK0680765T3 (ja)
ES (1) ES2282992T3 (ja)
FI (1) FI120149B (ja)
IL (1) IL113595A (ja)
NO (1) NO951750L (ja)
PT (1) PT680765E (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089839A1 (en) * 2001-05-03 2002-11-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella catarrhalis
US20040126381A1 (en) * 1996-04-23 2004-07-01 Xin-Xing Gu Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
GB9904183D0 (en) * 1999-02-24 1999-04-14 Smithkline Beecham Biolog Novel compounds
US7101989B1 (en) 1999-07-09 2006-09-05 University Of North Carolina At Chapel Hill DsrA protein and polynucleotides encoding the same
GB0025486D0 (en) * 2000-10-17 2000-11-29 Smithkline Beecham Biolog Novel compounds
WO2004009621A2 (en) * 2002-07-24 2004-01-29 Id Biomedical Corporation Polypeptides of nontypeable haemophilus influenzae
IL308456A (en) 2005-04-08 2024-01-01 Wyeth Llc A multivalent pneumomuroral protein-polysaccharide conjugate preparation
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
KR101854904B1 (ko) * 2008-09-17 2018-06-20 헌터 이뮤놀로지 리미티드 비피막형 헤모필루스 인플루엔자 백신 및 그의 용도
KR102409709B1 (ko) 2021-11-30 2022-06-16 박정민 케이블 접속장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300632A (en) * 1986-11-18 1994-04-05 Research Foundation Of State University Of New York Method for purifying an outer membrane protein of Haemophilus influenzae
US5098997A (en) * 1987-12-11 1992-03-24 Praxis Biologics, Inc. Vaccines for Haemophilus influenzae
US5098987A (en) * 1989-07-13 1992-03-24 The United States Of America As Represented By The Secretary Of The Air Force Crosslinkable rigid-rod benzobisazole polymer
ATE226831T1 (de) 1993-05-18 2002-11-15 Univ Ohio State Res Found Impfstoff gegen mittelohrentzündung

Also Published As

Publication number Publication date
IL113595A (en) 2001-05-20
NO951750D0 (no) 1995-05-04
ATE356633T1 (de) 2007-04-15
DE69535422T2 (de) 2007-12-13
CA2148563A1 (en) 1995-11-06
FI120149B (fi) 2009-07-15
EP0680765B1 (en) 2007-03-14
DE69535422D1 (de) 2007-04-26
FI952144A0 (fi) 1995-05-04
US5770213A (en) 1998-06-23
NO951750L (no) 1995-11-06
ES2282992T3 (es) 2007-10-16
JP4236215B2 (ja) 2009-03-11
PT680765E (pt) 2007-05-31
IL113595A0 (en) 1995-08-31
FI952144A (fi) 1995-11-06
JPH08337598A (ja) 1996-12-24
AU704882B2 (en) 1999-05-06
USRE37741E1 (en) 2002-06-11
EP0680765A1 (en) 1995-11-08
KR950031108A (ko) 1995-12-18
KR100366482B1 (ko) 2003-08-02
CA2148563C (en) 2008-10-07
JP2009051859A (ja) 2009-03-12
AU1781495A (en) 1995-11-16

Similar Documents

Publication Publication Date Title
WO2000039299A3 (en) Streptococcus antigens
AP2000001886A0 (en) Group B streptococcus antigens.
ATE317013T1 (de) Antigen omp26 aus haemophilus influenzae
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
DE69535120D1 (de) L-Isoleucin produzierendes Bacterium und Verfahren zur Herstellung von L-Isoleucin durch Fermentation
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
DK0680765T3 (da) Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme
AU1915995A (en) Active immunization using a siderophore receptor protein
DE69329923T2 (de) Molkenprotein und molkenproteinhydrolysate, und verfahren zur herstellung
WO2001040280A3 (en) Composition and method for treating a microbial infection
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
FI960308A0 (fi) Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
DE69024392T2 (de) Verfahren zur Reinigungbvon Aussenmembran-Protein von Haemophilus influenzae
AU2548597A (en) Antibodies against avirulence/pathogenicity proteins of plant pathogens
DE60120357D1 (de) Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff
EP1950302A3 (en) Streptococcus antigens
AU603794C (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus
ATE92962T1 (de) Mikrobiologisches verfahren zur gewinnung eines proteins durch zuechtung eines mutanten bakterienstammes.
AU7158087A (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus